We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Eidos Therapeutics (EIDX) Looks Good: Stock Adds 6.4% in Session
Read MoreHide Full Article
Eidos Therapeutics, Inc. was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $43.70 –$52.64 in the past one-month time frame, witnessed a sharp increase yesterday.
The company's Zacks Consensus Estimate for the current quarter has moved higher over the past few weeks, suggesting that more solid trading could be ahead for Eidos Therapeutics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Eidos Therapeutics currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
Image: Bigstock
Eidos Therapeutics (EIDX) Looks Good: Stock Adds 6.4% in Session
Eidos Therapeutics, Inc. was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $43.70 –$52.64 in the past one-month time frame, witnessed a sharp increase yesterday.
The company's Zacks Consensus Estimate for the current quarter has moved higher over the past few weeks, suggesting that more solid trading could be ahead for Eidos Therapeutics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Eidos Therapeutics currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Eidos Therapeutics, Inc. Price
Eidos Therapeutics, Inc. price | Eidos Therapeutics, Inc. Quote
A better-ranked stock in the Medical - Biomedical and Genetics industry is Emergent Biosolutions Inc. (EBS - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>